Open Access
Med Buccale Chir Buccale
Volume 16, Number 2, avril 2010
Page(s) 113 - 117
Section Observations cliniques / Case reports
Published online 23 March 2010
  1. Davis SD, Schaller JWedgwood RJ. Job’s syndrome: recurrent, cold, staphylococcal abscesses. Lancet 1966;7:1013-5. [CrossRef] [PubMed] [Google Scholar]
  2. Buckley RH. Wray BBBelmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infections. Pediatrics 1972;49:59-70. [PubMed] [Google Scholar]
  3. Hill HR. The syndrom of hyperimmunoglobulinemia E and recurrent infections. Am J Dis Child 1982;136:767-71. [PubMed] [Google Scholar]
  4. Grimbacher B, Holland SMPuck JM. Hyper IgE syndromes. Immunol Rev 2005;203:244-50. [CrossRef] [PubMed] [Google Scholar]
  5. Freeman AF, Domngo DLHolland SM. HyperIgE (Job’s) syndrome: a primary immune deficiency with oral manifestations. Oral Dis 2009;15:2-7. [CrossRef] [PubMed] [Google Scholar]
  6. Ling JC, Freeman AF, Gharib AM Arai AE, Lederman RJ, Rosing DRHolland SM. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol 2007;122:255-8. [CrossRef] [PubMed] [Google Scholar]
  7. Domingo DL, Freeman AF, Davis J, Puck JM, Tianxia W, Holland SMHart JC. Novel intraoral phenotypes in hyperimmunoglobulinemia E syndrome. Oral Dis 2008;14:73-81. [PubMed] [Google Scholar]
  8. O’Connell AC, Puck JM, Grimbacher Facchetti F, Majorana A, Gallin JI, Malech HLHolland SM. Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:177-85. [CrossRef] [PubMed] [Google Scholar]
  9. Dreskin SC, Goldsmith PKGallin JI. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job’s) syndrome. Deficiency of anti-staphylococcus aureus immunoglobulin A. J Clin Invest 1985;75:26-34. [Google Scholar]
  10. Geha RS, Reinherz E, Leung D, Mc Kee KT, Schlossman SRosen FS. Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrom. J Clin Invest 1981;68:783-91. [CrossRef] [PubMed] [Google Scholar]
  11. Borges WG, Augustine NHHill HR. Defective interleukine-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome. J Pediatr 2000;136:176-80. [CrossRef] [PubMed] [Google Scholar]
  12. Holland SM, Deleo FR, Elloumi HZ Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis JTurner ML. STAT 3 mutations in the hyper-IgE syndrome. N Engl J Med 2007;357:1608-19. [CrossRef] [PubMed] [Google Scholar]
  13. Levy DELoomis CA. STAT 3 signaling and the hyper-IgE syndrome. N Engl J Med 2007;357:1655-57. [CrossRef] [PubMed] [Google Scholar]
  14. Ma CS, Chew GY, Simpson N Priyardashi A, Wong M, Grimbacher B, Fulcher DA, Tangye SGCook MC. Deficiency of the Th17 cells in hyper IgE syndrome due to mutations in STAT 3. J Exp Med 2008;205:1551-7. [CrossRef] [PubMed] [Google Scholar]
  15. De Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Jannière L, Fieschi C, Stéphan JL, Boileau C, Lyonnet S, Jondeau G, Cormier-Daire V, Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, Chandesris MO, Tron F, Gambineri E, Bianchi L, Rodriguez-Gallego C, Zitnik SE, Vasconcelos J, Guedes M, Vitor AB, Marodi L, Chapel H, Reid B, Roifman C, Nadal D, Reichenbach J, Caragol I, Garty BZ, Dogu F, Camcioglu Y, Gülle S, Sanal O, Fischer A, Abel L, Stockinger B, Picard CCasanova JL. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008;205:1543-50. [CrossRef] [PubMed] [Google Scholar]
  16. Weston WL. Cutaneous manifestations of defective host defenses. Pediatr Clin North Am 1977;24:395-407. [PubMed] [Google Scholar]
  17. Ishikawa I, Fukuda Y, Kitada H, Yuri T, Shinoda A, Hayakawa Y, Sawano KUsui T. Plasma exchange in a patient with hyper-IgE syndrome. Ann Allergy 1982;49:295-7. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.